Picture of Evotec SE logo

EVT Evotec SE Cashflow Statement

0.000.00%
de flag iconLast trade - 00:00
HealthcareSpeculativeMid CapNeutral

Annual cashflow statement for Evotec SE, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

2020
December 31st
2021
December 31st
C2022
December 31st
2023
December 31st
2024
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line6.25216-176-83.9-196
Depreciation
Amortisation
Deferred Taxes
Non-Cash Items23.9-16521150.2105
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital-48.9-0.57686.8-22.87.88
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Taxes Payable
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities44.712220636.418.2
Capital Expenditures-99.1-119-181-216-132
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-56-125-23120361
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-155-244-413-13.3-71.2
Financing Cash Flow Items-5.73-12.9-9.72
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities246398-58.172-161
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash146277-28495.8-205